Bioengineers Present Glucose Monitor Tattoo Prototype
|
By LabMedica International staff writers Posted on 25 Jan 2015 |

Image: Bioengineers have tested a flexible and easy to wear temporary tattoo that both extracts and measures the level of glucose in the fluid in between skin cells (Photo courtesy of the University of California, San Diego).
A team of bioengineers has presented a prototype "proof-of-concept" version of a temporary tattoo that is able to extract and measure the level of glucose in the fluid between human skin cells.
The flexible, easy to wear device consists of a pattern of electrodes printed on temporary tattoo paper that is attached to the skin. When a mild electrical current is applied to the skin for about 10 minutes, sodium ions and glucose molecules in the interstitial fluid migrate toward the tattoo's electrodes. A sensor built into the tattoo measures the strength of the electrical charge produced by the glucose to determine the patient's overall glucose level.
In a preliminary study, tattoos were applied to seven men and women between the ages of 20 and 40 with no history of diabetes. The volunteers were fed a carbohydrate-rich meal, and glucose levels were monitored by the tattoo and compared to those obtained by the traditional finger-stick method. Results showed that the tattoos detected the glucose spike following the meal with the same level of accuracy as the finger-stick.
"The concentration of glucose extracted by the noninvasive tattoo device is almost hundred times lower than the corresponding level in the human blood," said first author Amay Bandodkar, a graduate researcher at the University of California, San Diego (USA). "Thus we had to develop a highly sensitive glucose sensor that could detect such low levels of glucose with high selectivity. Eventually the instrument will also have Bluetooth readout capabilities to send this information directly to the patient's doctor in real-time or store data in the cloud. Presently the tattoo sensor can easily survive for a day. These are extremely inexpensive—a few cents—and hence can be replaced without much financial burden on the patient."
The paper describing the potential for glucose monitoring with a noninvasive flexible tattoo was published in the December 12, 2014, online edition of the journal Analytical Chemistry.
Related Links:
University of California, San Diego
The flexible, easy to wear device consists of a pattern of electrodes printed on temporary tattoo paper that is attached to the skin. When a mild electrical current is applied to the skin for about 10 minutes, sodium ions and glucose molecules in the interstitial fluid migrate toward the tattoo's electrodes. A sensor built into the tattoo measures the strength of the electrical charge produced by the glucose to determine the patient's overall glucose level.
In a preliminary study, tattoos were applied to seven men and women between the ages of 20 and 40 with no history of diabetes. The volunteers were fed a carbohydrate-rich meal, and glucose levels were monitored by the tattoo and compared to those obtained by the traditional finger-stick method. Results showed that the tattoos detected the glucose spike following the meal with the same level of accuracy as the finger-stick.
"The concentration of glucose extracted by the noninvasive tattoo device is almost hundred times lower than the corresponding level in the human blood," said first author Amay Bandodkar, a graduate researcher at the University of California, San Diego (USA). "Thus we had to develop a highly sensitive glucose sensor that could detect such low levels of glucose with high selectivity. Eventually the instrument will also have Bluetooth readout capabilities to send this information directly to the patient's doctor in real-time or store data in the cloud. Presently the tattoo sensor can easily survive for a day. These are extremely inexpensive—a few cents—and hence can be replaced without much financial burden on the patient."
The paper describing the potential for glucose monitoring with a noninvasive flexible tattoo was published in the December 12, 2014, online edition of the journal Analytical Chemistry.
Related Links:
University of California, San Diego
Latest Clinical Chem. News
- New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
- Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
- Study Compares Analytical Performance of Quantitative Hepatitis B Surface Antigen Assays
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







